
Hematology-OncologyFollicular lymphomaHistologic Transformation
Transforming Care in Follicular Lymphoma: Outcomes and Prognostic Insights in the Rituximab Era
By MedXY|Sep 30, 2026
This study analyzes treatment patterns, outcomes, and prognostic factors in 344 patients with transformed follicular lymphoma in the rituximab era, revealing poor event-free survival but moderate overall survival and high relapse rates, gui